Abstract
Hepatocellular adenomas (HCAs) are clinically relevant benign liver lesions that commonly occur in women on hormonal contraceptives. In this issue of Cancer Cell, Pilati and colleagues present an integrative multi-"omics"-based analysis of HCA and identify recurrent genetic alterations associated with adenoma-carcinoma transition and new drugable targets.
| Original language | English |
|---|---|
| Journal | Cancer Cell |
| Volume | 25 |
| Issue number | 4 |
| Pages (from-to) | 409-411 |
| Number of pages | 3 |
| ISSN | 1535-6108 |
| DOIs | |
| Publication status | Published - 14.04.2014 |
Funding
J.U.M. is supported by a grant from the German Research Foundation (MA 4443/2-1).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Next-generation genomic profiling of hepatocellular adenomas: A new era of individualized patient care'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver